Home/Filings/4/0001415889-22-012558
4//SEC Filing

Gendreau Roger Michael 4

Accession 0001415889-22-012558

CIK 0001818844other

Filed

Dec 13, 7:00 PM ET

Accepted

Dec 14, 6:30 PM ET

Size

5.3 KB

Accession

0001415889-22-012558

Insider Transaction Report

Form 4
Period: 2022-12-12
Gendreau Roger Michael
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Stock Option (right to buy)

    2022-12-12+80,00080,000 total
    Exercise: $0.28Exp: 2032-12-12Common Stock (80,000 underlying)
Footnotes (1)
  • [F1]The stock option vests one-third on December 12, 2023 and 1/24th monthly thereafter.

Issuer

Virios Therapeutics, Inc.

CIK 0001818844

Entity typeother

Related Parties

1
  • filerCIK 0001826131

Filing Metadata

Form type
4
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 6:30 PM ET
Size
5.3 KB